Trending News
News
News
CEA Initiates the French Nanobiotech Cluster
The cluster, called NanoBio, aims to foster the technological and economical development in the bioengineering field, taking advantage of the CEA’s 10-years experience in biochips and bioMEMS research.
News
DeltaNu Wins Prestigious R&D 100 Award
The product, released earlier this year by DeltaNu, is the Investigator which is used to follow high speed chemical reactions that are accelerated by microwaves.
News
Chiral Quest Subsidiary Signs License Agreement with
This agreement provides Merck with access to a broad range of proprietary ligands and catalysts.
News
Geneservice and RZPD to distribute DNABook™
The book comprises the largest collection to date of complete mouse genes, with 60,770 full-length mouse cDNA clones spotted onto paper and bound in an A5 size book.
News
Key Genetic Mutations in Brain Tumors Identified by Scientists
Recent studies have shown receptor tyrosine kinases to be cell regulators responsible for rapid cell growth in cancers, including colorectal, lymphoma, breast, and ovarian cancer.
News
Nucleofector® Technology Combined with the Cell Line Collection
American Type Culture Collection will supply amaxa with cell lines to develop and optimize protocols using amaxa's Nucleofector® technology.
News
Tecan at Biotechnica 2005
Visitors to the show will have opportunity to see the features on Tecan's Freedom EVO® series of automated workstations, the HS 400 Pro fully automated hybridization station, the high sensitivity LS Reloaded Scanner and the flexible Safire2 microplate reader.
News
Vion Licenses Heterocyclic Hydrazones
The hydrazones have unique chemical structures and biologic activity, and have shown potent cytotoxic activity in the National Cancer Institute's tumor cell panels and in vivo anticancer testing.
News
Renowned Neuroscientist Joins CytRx Scientific Advisory Board
Professor Burnstock, who played a major role in the development of CytRx's lead small molecule drug candidate arimoclomol, joins CytRx's Advisory Board.
News
Clinical Data to Acquire Icoria
Clinical Data will acquire Icoria in an all-stock transaction valued at approximately $12.5 million based on the closing price of Clinical Data’s Common Stock on Friday, September 16.
Advertisement